NCT04121429

Stopping Cardiovascular Treatments and Mortality in a MICU

Impact on Mortality of Cardiovascular Treatments Interruption in a Medical Intensive Care Unit

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.

Detailed description

Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. Few studies have investigated the outcome impact of medications interruption and/or modifications following hospital admission. We did consider that it might be interesting to study whether treatment continuation, interruption, and/or re-introduction following ICU admission may modify patients' outcome either in the ICU or following hospital discharge (at 3,6 and 12 months).

Conditions

• Critical Care
• Medication
• Cardiovascular Diseases
• Outcome, Fatal

Interventions

Type	Name	Description
OTHER	Observation	No intervention will be performed

Timeline

• Start date: 2019-05-02
• Primary completion: 2019-11-02
• Completion: 2019-11-02
• First posted: 2019-10-09
• Last updated: 2019-10-09

Locations

1 site across 1 country: France